These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 26105145)
1. Pharmacokinetics of sufentanil during long-term infusion in critically ill pediatric patients. Bartkowska-Śniatkowska A; Bienert A; Wiczling P; Rosada-Kurasińska J; Zielińska M; Warzybok J; Borsuk A; Tibboel D; Kaliszan R; Grześkowiak E J Clin Pharmacol; 2016 Jan; 56(1):109-15. PubMed ID: 26105145 [TBL] [Abstract][Full Text] [Related]
2. Flip-Flop Phenomenon in Epidural Sufentanil Pharmacokinetics: A Population Study in Children and Infants. Borsuk A; Wołoszczuk-Gębicka B; Bartkowska-Śniatkowska A; Rosada-Kurasińska J; Bienert A; Wiczling P J Clin Pharmacol; 2017 Sep; 57(9):1194-1206. PubMed ID: 28510304 [TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy. Hahn J; Yang S; Min KL; Kim D; Jin BH; Park C; Park MS; Wi J; Chang MJ Crit Care; 2019 Jul; 23(1):248. PubMed ID: 31288863 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patients. Ethuin F; Boudaoud S; Leblanc I; Troje C; Marie O; Levron JC; Le Moing JP; Assoune P; Eurin B; Jacob L Intensive Care Med; 2003 Nov; 29(11):1916-20. PubMed ID: 12923616 [TBL] [Abstract][Full Text] [Related]
5. Performance of target-controlled sufentanil infusion in obese patients. Slepchenko G; Simon N; Goubaux B; Levron JC; Le Moing JP; Raucoules-Aimé M Anesthesiology; 2003 Jan; 98(1):65-73. PubMed ID: 12502981 [TBL] [Abstract][Full Text] [Related]
6. Linearity of pharmacokinetics and model estimation of sufentanil. Gepts E; Shafer SL; Camu F; Stanski DR; Woestenborghs R; Van Peer A; Heykants JJ Anesthesiology; 1995 Dec; 83(6):1194-204. PubMed ID: 8533912 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of sufentanil administered with 0.2% ropivacaine as a continuous epidural infusion for postoperative pain relief in infants. Woloszczuk-Gebicka B; Grabowski T; Borucka B; Karas-Trzeciak M Paediatr Anaesth; 2014 Sep; 24(9):962-7. PubMed ID: 24824135 [TBL] [Abstract][Full Text] [Related]
8. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients. Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM Br J Clin Pharmacol; 2004 Feb; 57(2):135-45. PubMed ID: 14748812 [TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%. Knibbe CA; Zuideveld KP; DeJongh J; Kuks PF; Aarts LP; Danhof M Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748 [TBL] [Abstract][Full Text] [Related]
10. Factors Contributing to Fentanyl Pharmacokinetic Variability Among Diagnostically Diverse Critically Ill Children. Hagos FT; Horvat CM; Au AK; Conley YP; Li L; Poloyac SM; Kochanek PM; Clark RSB; Empey PE Clin Pharmacokinet; 2019 Dec; 58(12):1567-1576. PubMed ID: 31168770 [TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine pharmacokinetics in pediatric intensive care--a pooled analysis. Potts AL; Anderson BJ; Warman GR; Lerman J; Diaz SM; Vilo S Paediatr Anaesth; 2009 Nov; 19(11):1119-29. PubMed ID: 19708909 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of S-ketamine during prolonged sedation at the pediatric intensive care unit. Flint RB; Brouwer CNM; Kränzlin ASC; Lie-A-Huen L; Bos AP; Mathôt RAA Paediatr Anaesth; 2017 Nov; 27(11):1098-1107. PubMed ID: 29030928 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of Dexmedetomidine in Infants and Children After Orthotopic Liver Transplantation. Damian MA; Hammer GB; Elkomy MH; Frymoyer A; Drover DR; Su F Anesth Analg; 2020 Jan; 130(1):209-216. PubMed ID: 30198929 [TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of omeprazole in critically ill pediatric patients. Solana MJ; Colom H; López-Herce J; Urbano J; González R; López J; Manzanares C; Carrillo A Ther Drug Monit; 2014 Aug; 36(4):519-27. PubMed ID: 24365987 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic assessment of sufentanil in cardiac surgery. Manfio JL; Santos LM; Carmona MJ; Dos Santos MB; Santos SR Drug Res (Stuttg); 2013 Oct; 63(10):495-500. PubMed ID: 23780500 [TBL] [Abstract][Full Text] [Related]
17. NONMEM population pharmacokinetic studies of cytosine arabinoside after high-dose and after loading bolus followed by continuous infusion of the drug in pediatric patients with leukemias. Periclou AP; Avramis VI Cancer Chemother Pharmacol; 1996; 39(1-2):42-50. PubMed ID: 8995498 [TBL] [Abstract][Full Text] [Related]
18. Population Pharmacokinetics of Fentanyl in the Critically Ill. Choi L; Ferrell BA; Vasilevskis EE; Pandharipande PP; Heltsley R; Ely EW; Stein CM; Girard TD Crit Care Med; 2016 Jan; 44(1):64-72. PubMed ID: 26491862 [TBL] [Abstract][Full Text] [Related]
19. Aspects of pharmacokinetics and pharmacodynamics of sufentanil in pediatric practice. Lundeberg S; Roelofse JA Paediatr Anaesth; 2011 Mar; 21(3):274-9. PubMed ID: 20849451 [TBL] [Abstract][Full Text] [Related]
20. Protein Binding and Population Pharmacokinetics of Dexmedetomidine after Prolonged Infusions in Adult Critically Ill Patients. Yan X; Tse AHW; Lee A; Zhang L; Yang M; Zuo Z; Joynt GM Clin Ther; 2021 Aug; 43(8):1356-1369.e1. PubMed ID: 34304911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]